Profound Medical’s (TSX:PRN; OTCQX:PRFMD) common shares have been certified for listing on The Nasdaq Stock Market, with trading slated to begin on Oct. 29 under the stock symbol “PROF.” The company’s common shares will continue to trade on the Toronto Stock Exchange under the symbol “PRN.”
“The United States is a key target market for the TULSA-PRO system, which recently received 510(k) clearance from the FDA, and many of our shareholders are U.S.-based,” CEO Dr. Arun Menawat said in a statement.
“As we launch TULSA-PRO in the U.S., we view this Nasdaq listing as a natural extension of our growth plan,” he added.
